Current status of anticoagulant therapy for non-valvular atrial fibrillation in elderly patients

VernacularTitle:老年非瓣膜性心房颤动患者的抗凝治疗现状
Author: Hong LI ; Haiyan SHAN
From: Chinese Journal of General Practitioners 2021;20(1):107-110
CountryChina
Language:Chinese
Abstract: Atrial fibrillation (AF) is one of the most common and age-related persistent arrhythmias. With the increase of age, the prevalence of AF and the incidence of atrial fibrillation-related stroke are increased. Due to the decline of cognition and function of various organs, coupled with the increase of comorbities and complications, the types of drug use also are increased in elderly patients, and their anticoagulant therapy has become complex. New anticoagulant drugs increase the choice of treatment in elderly patients with AF. This article reviews the clinical characteristics, necessity, challenge and drug selection of anticoagulant therapy in elderly patients with non-valvular AF to provide information for rational anticoagulant therapy.